MeSH tree: D02.092.471.683.152.110.200.500
The use of medications for Attention-Deficit Hyperactivity Disorder (ADHD) has increased substantially across Europe over the past decade, with the steepest rises seen among adults—particularly women—according to a large ...
Jan 25, 2026
0
19
Not long ago, most people thought of attention deficit hyperactivity disorder, or ADHD, as a childhood condition that would eventually be outgrown. Now it's everywhere.
Nov 24, 2025
0
10
Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.
Nov 10, 2025
0
39
Prescriptions for attention deficit hyperactivity disorder (ADHD) in England have risen 18% year on year since the pandemic. This is higher than previously reported, and masks wide regional variations in prescribing rates, ...
Mar 11, 2025
0
16
Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers.
Feb 3, 2025
0
29
A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction.
Jan 2, 2025
0
47
Attention-deficit hyperactivity disorder (ADHD) is the most diagnosed childhood neurological disorder in Australia.
Oct 4, 2024
0
22
Each year, the National Drug and Alcohol Research Center at UNSW Sydney surveys hundreds of people who regularly use drugs in Australia to understand trends in substance use around the country.
Sep 22, 2024
0
52
The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.
Sep 5, 2024
0
49
The two top officers of a telehealth company that began to distribute ADHD drugs widely during the pandemic have been charged with health care fraud, the U.S. Department of Justice announced Thursday.
Jun 14, 2024
0
82
